Back to search
FDAFDA · Food and drugs·Recall number D-0444-2026

Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91

Published April 15, 2026 · Recall initiated: March 17, 2026

Summary

FDA records drug Class II recall D-0444-2026, published April 15, 2026 and initiated March 17, 2026. Recalling firm: Viatris, Inc.; Status: Ongoing; Lot: Lot# 8177156, Exp Date: 02/28/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if XANAX has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
XANAX
Manufacturer
Viatris, Inc.
Distributor
US Nationwide.
UPC
0358151506910
Lot
Lot# 8177156, Exp Date: 02/28/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91 recalled?

Yes. FDA published recall D-0444-2026 on April 15, 2026. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: XANAX. UPC: 0358151506910.